VEGFC and lymphedema: For example, Szuba and colleagues showed that a single 100 μg dose of recombinant human VEGF-C into the surgical bed of a rabbit ear model of lymphedema resulted in histologic evidence of lymphangiogenesis, decreased dermal hypercellularity, and improvements in Indocyanine Green (ICG)-based quantifications of lymphatic function compared to controls.